Wessex Medical Research

High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT

J. Sweetenham, G. Taghipour, D Milligan et al. · Bone Marrow Transplantation · 1997 · 96 citations

Lymphoid Neoplasia, Cell Therapy, Oncology +10

Cost‐minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B‐cell non‐Hodgkin's lymphoma in the U.K.

John Sweetenham, K Hieke, Matthew Kerrigan et al. · British Journal of Haematology · 1999 · 58 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Optimal Therapy +15

Isolation and culture of endothelial cells from human bone marrow

Lisa C. Masek, John Sweetenham · British Journal of Haematology · 1994 · 45 citations

Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy

Ellen Copson, Joe McKendrick, N. P. Hennessey et al. · British Journal of Urology · 2004 · 31 citations

ChlVPP chemotherapy in advanced Hodgkin's disease

J McKendrick, Graham M. Mead, John Sweetenham et al. · European Journal of Cancer and Clinical Oncology · 1989 · 21 citations

Lymphoid Neoplasia, Medicine, Pathology +5